Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Assessment of major salivary gland ultrasonography in Sjögren's syndrome. A comparison between bedside and post-examination evaluations.

Hammenfors DS, Causevic H, Assmus J, Brun JG, Jonsson R, Jonsson MV.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):153-158. Epub 2019 Aug 28.

2.

Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.

Davies R, Sarkar I, Hammenfors D, Bergum B, Vogelsang P, Solberg SM, Gavasso S, Brun JG, Jonsson R, Appel S.

Front Immunol. 2019 Feb 21;10:281. doi: 10.3389/fimmu.2019.00281. eCollection 2019.

3.

Juvenile Sjögren's syndrome: clinical characteristics with focus on salivary gland ultrasonography.

Hammenfors DS, Valim V, Bica BERG, Pasoto SG, Lilleby V, Nieto-González JC, Silva CA, Mossel E, Pereira RMR, Coelho A, Bootsma H, Thatayatikom A, Brun JG, Jonsson MV.

Arthritis Care Res (Hoboken). 2019 Jan 30. doi: 10.1002/acr.23839. [Epub ahead of print]

PMID:
30697959
4.

Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health.

Beyer K, Zaura E, Brandt BW, Buijs MJ, Brun JG, Crielaard W, Bolstad AI.

PLoS One. 2018 Sep 19;13(9):e0202278. doi: 10.1371/journal.pone.0202278. eCollection 2018.

5.

Marine ω-3, vitamin D levels, disease outcome and periodontal status in rheumatoid arthritis outpatients.

Beyer K, Lie SA, Kjellevold M, Dahl L, Brun JG, Bolstad AI.

Nutrition. 2018 Nov;55-56:116-124. doi: 10.1016/j.nut.2018.03.054. Epub 2018 Apr 4.

6.

T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome.

Brokstad KA, Fredriksen M, Zhou F, Bergum B, Brun JG, Cox RJ, Skarstein K.

Scand J Immunol. 2018 Jun 8:e12679. doi: 10.1111/sji.12679. [Epub ahead of print]

7.

Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.

Davies R, Hammenfors D, Bergum B, Vogelsang P, Gavasso S, Brun JG, Jonsson R, Appel S.

Eur J Immunol. 2018 Jul;48(7):1217-1227. doi: 10.1002/eji.201747213. Epub 2018 Apr 26. Erratum in: Eur J Immunol. 2019 May;49(5):816.

8.

Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations.

Davies R, Hammenfors D, Bergum B, Jakobsen K, Solheim M, Vogelsang P, Brun JG, Bryceson Y, Jonsson R, Appel S.

Scand J Immunol. 2017 Dec;86(6):491-502. doi: 10.1111/sji.12622.

9.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

10.

Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.

Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Cunninghame Graham DS, Patel K, Adler AJ, Farris AD, Brennan MT, Chodosh J, Gopalakrishnan R, Weisman MH, Venuturupalli S, Wallace DJ, Hefner KS, Houston GD, Huang AJW, Hughes PJ, Lewis DM, Radfar L, Vista ES, Edgar CE, Rohrer MD, Stone DU, Vyse TJ, Harley JB, Gaffney PM, James JA, Turner S, Alevizos I, Anaya JM, Rhodus NL, Segal BM, Montgomery CG, Scofield RH, Kovats S, Mariette X, Rönnblom L, Witte T, Rischmueller M, Wahren-Herlenius M, Omdal R, Jonsson R, Ng WF; for UK Primary Sjögren's Syndrome Registry, Nordmark G, Lessard CJ, Sivils KL.

PLoS Genet. 2017 Jun 22;13(6):e1006820. doi: 10.1371/journal.pgen.1006820. eCollection 2017 Jun.

11.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, De Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M; EULAR-SS Task Force Big Data Consortium.

Ann Rheum Dis. 2017 Jun;76(6):1042-1050. doi: 10.1136/annrheumdis-2016-209952. Epub 2016 Nov 29.

PMID:
27899373
12.

Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.

Balarini GM, Zandonade E, Tanure L, Ferreira GA, Sardenberg WM, Serrano ÉV, Dias CC, Navarro TP, Nordal HH, Mydel PM, Brun JG, Brokstad KA, Gerdts E, Jonsson R, Valim V.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1006-1012. Epub 2016 Sep 8.

PMID:
27749218
13.

Sjögren's syndrome patients with ectopic germinal centers present with a distinct salivary proteome.

Delaleu N, Mydel P, Brun JG, Jonsson MV, Alimonti A, Jonsson R.

Rheumatology (Oxford). 2016 Jun;55(6):1127-37. doi: 10.1093/rheumatology/kew013. Epub 2016 Feb 26.

PMID:
26921905
14.

Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.

Valim V, Gerdts E, Jonsson R, Ferreira GA, Brokstad KA, Brun JG, Midtbø H, Mydel PM.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):133-42. Epub 2016 Jan 20. Review.

PMID:
26812164
15.

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment.

Selaas O, Nordal HH, Halse AK, Brun JG, Jonsson R, Brokstad KA.

Int J Rheumatol. 2015;2015:276815. doi: 10.1155/2015/276815. Epub 2015 Dec 16.

16.

Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.

Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.

Scand J Rheumatol. 2016 Jul;45(4):274-81. doi: 10.3109/03009742.2015.1107128. Epub 2016 Jan 15.

PMID:
26767827
17.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

18.

TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.

Karlsen M, Jonsson R, Brun JG, Appel S, Hansen T.

Scand J Immunol. 2015 Dec;82(6):523-31. doi: 10.1111/sji.12368.

19.

Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.

Karlsen M, Hansen T, Nordal HH, Brun JG, Jonsson R, Appel S.

PLoS One. 2015 Mar 19;10(3):e0120383. doi: 10.1371/journal.pone.0120383. eCollection 2015.

20.

High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.

Delaleu N, Mydel P, Kwee I, Brun JG, Jonsson MV, Jonsson R.

Arthritis Rheumatol. 2015 Apr;67(4):1084-95. doi: 10.1002/art.39015.

21.

Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.

Hammenfors DS, Brun JG, Jonsson R, Jonsson MV.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):56-62. Epub 2014 Dec 22.

22.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
23.

The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.

Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK, Hammer HB.

BMC Musculoskelet Disord. 2014 Oct 4;15:335. doi: 10.1186/1471-2474-15-335.

24.

The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.

Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, Hirschfield GM, Xie G, Coltescu C, Amos C, Li H, Ice JA, Nath SK, Mariette X, Bowman S; UK Primary Sjögren's Syndrome Registry, Rischmueller M, Lester S, Brun JG, Gøransson LG, Harboe E, Omdal R, Cunninghame-Graham DS, Vyse T, Miceli-Richard C, Brennan MT, Lessard JA, Wahren-Herlenius M, Kvarnström M, Illei GG, Witte T, Jonsson R, Eriksson P, Nordmark G, Ng WF; UK Primary Sjögren's Syndrome Registry, Anaya JM, Rhodus NL, Segal BM, Merrill JT, James JA, Guthridge JM, Scofield RH, Alarcon-Riquelme M, Bae SC, Boackle SA, Criswell LA, Gilkeson G, Kamen DL, Jacob CO, Kimberly R, Brown E, Edberg J, Alarcón GS, Reveille JD, Vilá LM, Petri M, Ramsey-Goldman R, Freedman BI, Niewold T, Stevens AM, Tsao BP, Ying J, Mayes MD, Gorlova OY, Wakeland W, Radstake T, Martin E, Martin J, Siminovitch K, Moser Sivils KL, Gaffney PM, Langefeld CD, Harley JB, Kaufman KM.

Hum Mol Genet. 2015 Jan 15;24(2):582-96. doi: 10.1093/hmg/ddu455. Epub 2014 Sep 8.

25.

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.

Koro C, Bielecka E, Dahl-Knudsen A, Enghild JJ, Scavenius C, Brun JG, Binder V, Hellvard A, Bergum B, Jonsson R, Potempa J, Blom AM, Mydel P.

Eur J Immunol. 2014 Nov;44(11):3403-12. doi: 10.1002/eji.201444869. Epub 2014 Oct 20.

26.

Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.

Vogelsang P, Karlsen M, Brun JG, Jonsson R, Appel S.

Arthritis Res Ther. 2014 Aug 11;16(4):R166. doi: 10.1186/ar4682.

27.

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2015 May;74(5):859-66. doi: 10.1136/annrheumdis-2013-204615. Epub 2014 Jan 17.

PMID:
24442883
28.

Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjögren's syndrome.

Nordal HH, Brun JG, Halse AK, Madland TM, Fagerhol MK, Jonsson R.

Scand J Rheumatol. 2014;43(1):76-8. doi: 10.3109/03009742.2013.848930. Epub 2013 Dec 3. No abstract available.

PMID:
24295066
29.

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.

Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Jazebi H, Cunninghame Graham DS, Grandits ME, Nazmul-Hossain AN, Patel K, Adler AJ, Maier-Moore JS, Farris AD, Brennan MT, Lessard JA, Chodosh J, Gopalakrishnan R, Hefner KS, Houston GD, Huang AJ, Hughes PJ, Lewis DM, Radfar L, Rohrer MD, Stone DU, Wren JD, Vyse TJ, Gaffney PM, James JA, Omdal R, Wahren-Herlenius M, Illei GG, Witte T, Jonsson R, Rischmueller M, Rönnblom L, Nordmark G, Ng WF; UK Primary Sjögren's Syndrome Registry, Mariette X, Anaya JM, Rhodus NL, Segal BM, Scofield RH, Montgomery CG, Harley JB, Sivils KL.

Nat Genet. 2013 Nov;45(11):1284-92. doi: 10.1038/ng.2792. Epub 2013 Oct 6.

30.
31.

A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Norheim KB, Le Hellard S, Nordmark G, Harboe E, Gøransson L, Brun JG, Wahren-Herlenius M, Jonsson R, Omdal R.

Rheumatol Int. 2014 Feb;34(2):191-7. doi: 10.1007/s00296-013-2850-9. Epub 2013 Sep 3.

PMID:
23999819
32.

Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.

Nordmark G, Wang C, Vasaitis L, Eriksson P, Theander E, Kvarnström M, Forsblad-d'Elia H, Jazebi H, Sjöwall C, Reksten TR, Brun JG, Jonsson MV, Johnsen SJ, Wahren-Herlenius M, Omdal R, Jonsson R, Bowman S, Ng WF, Eloranta ML, Syvänen AC; UK Primary Sjögren’s Syndrome Registry.

Scand J Immunol. 2013 Nov;78(5):447-54. doi: 10.1111/sji.12101.

33.

Genetic associations to germinal centre formation in primary Sjogren's syndrome.

Reksten TR, Johnsen SJ, Jonsson MV, Omdal R, Brun JG, Theander E, Eriksson P, Wahren-Herlenius M, Jonsson R, Nordmark G.

Ann Rheum Dis. 2014 Jun;73(6):1253-8. doi: 10.1136/annrheumdis-2012-202500. Epub 2013 Apr 20.

PMID:
23606706
34.

No association of primary Sjögren's syndrome with Fcγ receptor gene variants.

Haldorsen K, Appel S, Le Hellard S, Bruland O, Brun JG, Omdal R, Kristjansdottir G, Theander E, Fernandes CP, Kvarnström M, Eriksson P, Rönnblom L, Herlenius MW, Nordmark G, Jonsson R, Bolstad AI.

Genes Immun. 2013 Jun;14(4):234-7. doi: 10.1038/gene.2013.12. Epub 2013 Apr 4.

PMID:
23552400
35.

[A woman in her thirties with pain in her fingers and toes].

Power ØA, Brun JG, Blomberg B.

Tidsskr Nor Laegeforen. 2012 Nov 12;132(21):2401-3. doi: 10.4045/tidsskr.12.0379. Norwegian.

36.

Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study.

Johnsen SJ, Brun JG, Gøransson LG, Småstuen MC, Johannesen TB, Haldorsen K, Harboe E, Jonsson R, Meyer PA, Omdal R.

Arthritis Care Res (Hoboken). 2013 May;65(5):816-21. doi: 10.1002/acr.21887.

37.

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.

Nordström D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V, Kajalainen A, Brun JG, Proven A, Ljung L, Kautiainen H, Pettersson T.

J Rheumatol. 2012 Oct;39(10):2008-11. doi: 10.3899/jrheum.111549. Epub 2012 Aug 1.

PMID:
22859346
38.

Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.

Bolstad AI, Le Hellard S, Kristjansdottir G, Vasaitis L, Kvarnström M, Sjöwall C, Johnsen SJ, Eriksson P, Omdal R, Brun JG, Wahren-Herlenius M, Theander E, Syvänen AC, Rönnblom L, Nordmark G, Jonsson R.

Ann Rheum Dis. 2012 Jun;71(6):981-8. doi: 10.1136/annrheumdis-2011-200446. Epub 2012 Jan 30.

PMID:
22294627
39.

Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions.

Fagerhol MK, Larsen A, Brun JG, Hammer HB, Angel K, Kvien TK, Kinne I, Madland TM.

Scand J Clin Lab Invest. 2012 Apr;72(2):129-36. doi: 10.3109/00365513.2011.643819. Epub 2012 Jan 17.

PMID:
22248048
40.

A five-year prospective study of fatigue in primary Sjögren's syndrome.

Haldorsen K, Bjelland I, Bolstad AI, Jonsson R, Brun JG.

Arthritis Res Ther. 2011;13(5):R167. doi: 10.1186/ar3487. Epub 2011 Oct 13.

41.

Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome.

Reksten TR, Brokstad KA, Jonsson R, Brun JG, Jonsson MV.

Int Immunopharmacol. 2011 Dec;11(12):2125-9. doi: 10.1016/j.intimp.2011.09.006. Epub 2011 Sep 29.

PMID:
21964047
42.

Autoantigen-specific memory B cells in primary Sjögren's syndrome.

Aqrawi LA, Skarstein K, Bredholt G, Brun JG, Brokstad KA.

Scand J Immunol. 2012 Jan;75(1):61-8. doi: 10.1111/j.1365-3083.2011.02625.x.

43.

Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases.

Anaya JM, Kim-Howard X, Prahalad S, Cherñavsky A, Cañas C, Rojas-Villarraga A, Bohnsack J, Jonsson R, Bolstad AI, Brun JG, Cobb B, Moser KL, James JA, Harley JB, Nath SK.

Autoimmun Rev. 2012 Feb;11(4):276-80. doi: 10.1016/j.autrev.2011.07.007. Epub 2011 Aug 5. Review.

44.

Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome.

Appel S, Le Hellard S, Bruland O, Brun JG, Omdal R, Kristjansdottir G, Theander E, Nordmark G, Kvarnström M, Eriksson P, Rönnblom L, Wahren-Herlenius M, Jonsson R.

Ann Rheum Dis. 2011 Jul;70(7):1327-9. doi: 10.1136/ard.2010.138966. Epub 2011 Mar 30.

PMID:
21450750
45.

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22.

PMID:
21345815
46.

The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties.

Gøransson LG, Haldorsen K, Brun JG, Harboe E, Jonsson MV, Skarstein K, Time K, Omdal R.

Scand J Rheumatol. 2011 May;40(3):221-4. doi: 10.3109/03009742.2010.536164. Epub 2011 Jan 13.

PMID:
21231797
47.

Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome.

Szyszko EA, Brun JG, Skarstein K, Peck AB, Jonsson R, Brokstad KA.

Scand J Immunol. 2011 Jan;73(1):18-28. doi: 10.1111/j.1365-3083.2010.02475.x.

48.

Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.

Nordmark G, Kristjansdottir G, Theander E, Appel S, Eriksson P, Vasaitis L, Kvarnström M, Delaleu N, Lundmark P, Lundmark A, Sjöwall C, Brun JG, Jonsson MV, Harboe E, Gøransson LG, Johnsen SJ, Söderkvist P, Eloranta ML, Alm G, Baecklund E, Wahren-Herlenius M, Omdal R, Rönnblom L, Jonsson R, Syvänen AC.

Genes Immun. 2011 Mar;12(2):100-9. doi: 10.1038/gene.2010.44. Epub 2010 Sep 23.

PMID:
20861858
49.

Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome.

Cobb BL, Fei Y, Jonsson R, Bolstad AI, Brun JG, Rischmueller M, Lester SE, Witte T, Illei G, Brennan M, Bowman S, Moser KL, Harley JB, Sawalha AH.

Ann Rheum Dis. 2010 Sep;69(9):1731-2. doi: 10.1136/ard.2009.122903. Epub 2010 Mar 9. No abstract available.

50.

MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity.

Vetti N, Alsing R, Kråkenes J, Rørvik J, Gilhus NE, Brun JG, Espeland A.

Neuroradiology. 2010 Mar;52(3):215-23. doi: 10.1007/s00234-009-0650-4.

PMID:
20058001

Supplemental Content

Support Center